These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9374514)

  • 41. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro.
    Schön E; Jahn S; Kiessig ST; Demuth HU; Neubert K; Barth A; Von Baehr R; Ansorge S
    Eur J Immunol; 1987 Dec; 17(12):1821-6. PubMed ID: 2891539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.
    Péloponèse JM; Grégoire C; Opi S; Esquieu D; Sturgis J; Lebrun E; Meurs E; Collette Y; Olive D; Aubertin AM; Witvrow M; Pannecouque C; De Clercq E; Bailly C; Lebreton J; Loret EP
    C R Acad Sci III; 2000 Oct; 323(10):883-94. PubMed ID: 11098404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
    Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dipeptidyl peptidase IV in human T lymphocytes. An approach to the role of a membrane peptidase in the immune system.
    Schön E; Eichmann E; Grunow R; Jahn S; Kiessig ST; Volk HD; Ansorge S
    Biomed Biochim Acta; 1986; 45(11-12):1523-8. PubMed ID: 2883967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry.
    Cardaci S; Soster M; Bussolino F; Marchiò S
    FEBS Lett; 2013 Sep; 587(18):2943-51. PubMed ID: 23916815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.
    Mujtaba S; He Y; Zeng L; Farooq A; Carlson JE; Ott M; Verdin E; Zhou MM
    Mol Cell; 2002 Mar; 9(3):575-86. PubMed ID: 11931765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural model of the HIV-1 Tat(46-58)-TAR complex.
    Seewald MJ; Metzger AU; Willbold D; Rösch P; Sticht H
    J Biomol Struct Dyn; 1998 Dec; 16(3):683-92. PubMed ID: 10052624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat.
    Vendel AC; Lumb KJ
    Biochemistry; 2003 Feb; 42(4):910-6. PubMed ID: 12549909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of dipeptidyl peptidase IV (DP IV) by anti-DP IV antibodies and non-substrate X-X-Pro- oligopeptides ascertained by capillary electrophoresis.
    Hoffmann T; Reinhold D; Kähne T; Faust J; Neubert K; Frank R; Ansorge S
    J Chromatogr A; 1995 Nov; 716(1-2):355-62. PubMed ID: 8574390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
    Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
    J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative analysis of HIV-1 Tat variants.
    Pantano S; Carloni P
    Proteins; 2005 Feb; 58(3):638-43. PubMed ID: 15609368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
    Mujeeb A; Parslow TG; Yuan YC; James TL
    J Biomol Struct Dyn; 1996 Feb; 13(4):649-60. PubMed ID: 8906885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dipeptidyl peptidase IV (DP IV), a functional marker of the T lymphocyte system.
    Ansorge S; Schön E
    Acta Histochem; 1987; 82(1):41-6. PubMed ID: 2892340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.
    Yik JH; Chen R; Pezda AC; Samford CS; Zhou Q
    Mol Cell Biol; 2004 Jun; 24(12):5094-105. PubMed ID: 15169877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Furin cleavage of the HIV-1 Tat protein.
    Tikhonov I; Ruckwardt TJ; Berg S; Hatfield GS; David Pauza C
    FEBS Lett; 2004 May; 565(1-3):89-92. PubMed ID: 15135058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
    Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
    J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete 1H nuclear magnetic resonance assignments and structural characterization of a fusion protein of the alpha-amylase inhibitor tendamistat with the activation domain of the human immunodeficiency virus type 1 Tat protein.
    Freund J; Vértesy L; Koller KP; Wolber V; Heintz D; Kalbitzer HR
    J Mol Biol; 1995 Jul; 250(5):672-88. PubMed ID: 7623384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review).
    Kahne T; Lendeckel U; Wrenger S; Neubert K; Ansorge S; Reinhold D
    Int J Mol Med; 1999 Jul; 4(1):3-15. PubMed ID: 10373631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.